Status:
UNKNOWN
Immunotherapy of Chronic Kidney Failure
Lead Sponsor:
Immunitor LLC
Conditions:
Renal Failure Chronic
Eligibility:
All Genders
Phase:
PHASE2
Brief Summary
Kidney failure can result from inflammatory renal disease in the context of autoimmunity because the kidney is targeted by host's immune response against self. There are many causes to this, but abnor...
Eligibility Criteria
Inclusion
- Baseline level of creatinine twice above normal
Exclusion
- Baseline level of creatinine normal
Key Trial Info
Start Date :
June 16 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2021
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04377243
Start Date
June 16 2020
End Date
September 1 2021
Last Update
May 8 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Immunitor LLC
Ulaanbaatar, Mongolia